Cartesian Growth Corporation II
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RENEF research report →
Price Chart
About the company
Cartesian Growth Corporation II currently lacks significant ongoing business activities. Established in New York, New York, in 2021, its core objective is to execute a business combination, which may take various forms such as a merger, asset or share acquisition, reorganization, or other similar strategic transaction with one or more existing enterprises.
- CEO
- Peter Michael Yu
- IPO
- 2022
- Employees
- 2
- HQ
- New York, NY, US
Get TickerSpark's AI analysis on RENEF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $165.23M
- P/E
- 105.92
- PEG
- -0.46
- P/S
- 0.00
- P/B
- 2.80
- EV/EBITDA
- -140.29
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -8.99%
- ROIC
- -3.39%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-931,461
- Net Income
- $-1,512,540-118.4%
- EPS
- $-0.12-121.4%
- OCF Growth
- +5.0%
- FCF Growth
- +5.0%
- 52W High
- $12.71
- 52W Low
- $11.11
- 50D MA
- $12.71
- 200D MA
- $12.65
- Beta
- -0.01
- RSI (14)
- 55
- Avg Volume
- 4
No earnings-call transcripts are available for RENEF yet.
- Free Float
- 14.0%
- Shares Outstanding
- 13.00M
- Float Shares
- 1.83M
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 29, 23 | CGC II Sponsor LLC | other | 5,749,998 |
| Sep 29, 23 | CGC II Sponsor LLC | other | 5,749,998 |
| Sep 29, 23 | CGC II Sponsor LLC | other | 5,749,998 |
| Sep 29, 23 | CGC II Sponsor LLC | other | 5,749,998 |
| May 5, 22 | CGC II Sponsor LLC | other | 5,750,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our RENEF coverage
Recent articles, reports, and earnings notes.
No research on RENEF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RENEF report →Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.